by Brigham and Women’s Hospital Credit: Pixabay/CC0 Public Domain A peer-reviewed paper published in The New England Journal of Medicine provides data from the much-anticipated COVE study, which evaluated mRNA-1273, a vaccine candidate against COVID-19 manufactured by Moderna, Inc. Results from the primary analysis of the study, which will continue for two years, provide evidence that the vaccine...
By Jop de Vrieze Dec. 21, 2020 , 5:10 PM Science’s COVID-19 reporting is supported by the Pulitzer Center and the Heising-Simons Foundation. Severe allergy-like reactions in at least eight people who received the COVID-19 vaccine produced by Pfizer and BioNTech over the past 2 weeks may be due to a compound in the packaging...
The cold, hard fact is: Pfizer blazed a trail in creating a touted COVID-19 vaccine, but now it must help to equally pioneer an unprecedented way to distribute the drug across the United States and the globe, says a supply chain expert at Washington University in St. Louis. Delivering this breakthrough vaccine at steeply refrigerated...
Changing makeup of a specific protein has the potential to neutralize the virus. Researchers from McGill University are part of an international team led by the University of Buffalo, which has discovered a technique that could help increase the effectiveness of vaccines against SARS-CoV-2, the virus that causes COVID-19. The group’s study was published recently online...
UNIVERSITY OF WASHINGTON HEALTH SCIENCES/UW MEDICINE IMAGE: ARTIST’S DEPICTION OF AN ULTRAPOTENT COVID-19 VACCINE CANDIDATE IN WHICH 60 PIECES OF A CORONAVIRUS PROTEIN (RED) DECORATE NANOPARTICLES (BLUE AND WHITE). THE VACCINE CANDIDATE WAS DESIGNED USING METHODS DEVELOPED. An innovative nanoparticle vaccine candidate for the pandemic coronavirus produces virus-neutralizing antibodies in mice at levels ten-times greater...
by Chris Melore WUHAN, China — As the worldwide number of COVID-19 cases reaches five million, the search for a vaccine has taken an important step forward. Researchers say the first human trial of a possible vaccine has been found to be safe and may effectively fight the virus. Scientists in China say 108 healthy adults were given...
